Sichuan Huiyu Pharmaceutical Co., Ltd

This study tests a new drug called HYP-6589 in people with advanced solid tumors or a type of lung cancer (NSCLC) with specific gene changes. The drug is given alone or with other cancer drugs. The goal is to see if it is safe and helps shrink tumors. About 115 adults aged 18 to …

This study tests an experimental drug called HYP-2090PTSA in people with advanced solid tumors that have a specific genetic change called a KRAS mutation. The goal is to find the safest dose and see if the drug can shrink tumors. About 257 adults will take part in two phases: fir…

This study compares a generic version of the chemotherapy drug paclitaxel to the standard brand in 24 people with breast cancer. Participants receive one dose of each drug in random order to see if the generic works the same way in the body. The goal is to confirm the generic is …

This study tests an experimental drug called HY05350 in people with advanced solid tumors that have a protein called MSLN. The goal is to find safe doses and see if the drug can shrink tumors. About 262 adults aged 18 to 75 who have not responded to standard treatments will take …

This study tests a new drug called HY07121 in about 258 adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants receive the drug by infusion, and t…

This early-stage trial is testing a new drug called HY0001a in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, understand how the drug moves through the body, and see if it shows any early signs of shrinkin…

This early-stage study tests a new drug called HY-2003, which is a fat-dissolving injection for people with moderate to severe double chin. About 30 adults aged 18 to 65 will receive either the new drug, an existing treatment, or a placebo. The main goal is to check safety and ho…